INTRODUCTION {#sec1-1}
============

Prostate cancer (CaP) is the most common noncutaneous malignancy worldwide, with a still unresolved etiology. Advancing age is a known risk factor. The population of India is now over a billion with an estimated 1.5 million cases of cancer diagnosed per year; among those cases, CaP accounts for 20/million.\[[@ref1]\] Positive family history and high prevalence in certain ethnic groups are indicator of its genetic predisposition. Many gene polymorphisms such as those of metabolic pathway, hormone receptor,\[[@ref2][@ref3]\] and inflammation\[[@ref4][@ref5]\] have been implicated in CaP. A link between Toll-like receptor (TLR) polymorphism and CaP has also been suggested.\[[@ref6][@ref7]\]

*TLR-4* is required for innate immunity to gram-negative bacteria. Lipopolysaccharide found on the cell wall of gram-negative bacteria acts as a ligand for *TLR-4*. Arbour *et al*\[[@ref8]\] screened the entire coding region of *TLR-4* using single-strand conformation polymorphism and direct sequencing. This led to the identification of single-nucleotide polymorphism (SNP), an A→G substitution at nucleotide position +896 resulting in an amino acid substitution Asp299Gly in the third exon of the *TLR-4* gene. Asp299Gly was later shown to cosegregate with SNP Thr399Ile, a C→T substitution at nucleotide position 1196 also in the third exon of *TLR-4*. Both the SNPs are reported to have a positive correlation with the susceptibility to gram-negative sepsis, atherosclerosis, asthma, malaria, and *Helicobacter pylori*-induced gastric cancer and its precursors.\[[@ref9]--[@ref12]\] Recently, it was found that *TLR-4* Thr399Ile substitution may be a risk factor for gastritis and precancerous lesions in North Indian population.\[[@ref13]\] *TLR-4* is associated with generation of inflammation and such responses have been found to be associated with CaP.\[[@ref4][@ref5]\] Moreover, sequence variants in TLR gene cluster (TLR6--TLR1--TLR10) and in *TLR-4* are related to increased risk of CaP,\[[@ref6][@ref7]\] indicating a role of TLRs in its etiology. Thus, in this study an attempt was made to study the role of Asp299Gly and Thr399Ile SNPs as a risk factor for CaP in North Indian population.

MATERIALS AND METHODS {#sec1-2}
=====================

A total 198 histopathologically\[[@ref14]\] confirmed cases of CaP and 200 patients with symptomatic benign prostatic hyperplasia (BPH) having normal digital rectal examination and serum prostate specific antigen (PSA) \<4 ng/ml were included in the study. In all, 119 healthy males above 50 years of age with no symptoms of BPH, having normal size of prostate, and serum PSA level \<4 ng/ml served as controls. Patients from the state of Punjab, Haryana, Himachal Pradesh and Western Uttar Pradesh attending Urology Clinic of the Institute were included into the study. Thus, the analysis was done on the available samples comprising various regions of North India.

Analysis of *TLR-4* polymorphism {#sec2-1}
--------------------------------

### Preparation of genomic DNA {#sec3-1}

Genomic DNA was isolated from blood by the method described by Lahiri *et al*.\[[@ref15]\] Briefly, 1 ml of salt buffer TKM (Tris EDTA, KCl, MgCl~2~) was added to 1 ml blood sample and then 100 μl of Triton X-100 was added to lyse the cells. After centrifugation (6000 rpm for 15 min), the pellet obtained was washed twice with 1 ml TKM buffer followed by the addition of 10% SDS, 200 μg/ml proteinase K, and incubated for 2 hours at 65°C and then it was treated with 150 μg/ml RNase at 37°C for 1 hour. DNA extraction was done with phenol-chloroform-isoamyl alcohol. DNA was precipitated with ethanol, and the pellet collected by centrifugation was washed twice with 70% ethanol. The pellet was air dried and dissolved in 100 μl of Tris EDTA (TE) buffer and stored at 4°C after DNA quantification for further use. DNA sample was diluted and quantified spectrophotometrically (UVICON spectrophotometer, Pharmacia) and absorbance was read at 260 and 280 nm. The concentration of DNA in solution was quantified using the equation:

DNA concentration (μg/ml) = A~260~ × 50 × dilution factor/1000.

One OD at A~260~ corresponds to 50 μg of DNA/ml. The purity of DNA was checked by calculating the ratio of OD at A~260~ to A~280~ and the integrity was assessed by gel electrophoresis on 0.8% agarose gel.

Polymerase chain reaction {#sec2-2}
-------------------------

Polymerase chain reaction (PCR) amplification of *TLR-4* gene fragments was performed in Perkin Elmer thermocycler (USA) using gene-specific primers \[[Table 1](#T1){ref-type="table"}\]. Briefly, ^\~^200 ng of DNA isolated from blood sample was used in the reaction as template; 25 μl of PCR mix contained 2.5 μl of 10× Taq polymerase buffer, 20 pM of each primer (forward and reverse), 200 μM of each dNTPs, and 3.0 U of Taq DNA polymerase (Sigma, USA). The amplification was done for 35 cycles: 30 s denaturation at 94°C, 30s annealing at 55°C, 30 s extension at 72°C, with 10 min final extension at 72°C. The amplified product was visualized under UV transilluminator on 2% agarose gel containing ethidium bromide (0.5 μg/ml). DNA markers were used for the detection of size of the amplified products.

###### 

Primer sequence and PCR condition for *TLR-4* amplification
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Restriction fragment length polymorphism {#sec2-3}
----------------------------------------

*TLR-4* gene polymorphism was analyzed by restriction fragment length polymorphism (RFLP) technique.\[[@ref16]\] In this technique, alteration of the forward primers was done to create *Nco*1and *Hin*f1 restriction sites in the mutant alleles and it allows distinction between wild-type and mutant *TLR-4* alleles based on the presence of these restriction enzyme recognition sites. A portion of the resulting PCR product was digested for 5 hours with appropriate restriction enzymes (*Nco*1 for Asp299Gly and *Hin*f1 for Thr399Ile) and visualized on 2% agarose gel stained with ethidium bromide.

Statistical analysis {#sec2-4}
--------------------

Genotype distribution and allele frequencies in different groups were compared by chi-square analysis. Pearson\'s correlation and linear regression analysis were carried out to determine the correlation between different parameters. A *P* value less than 0.05 was significant. All statistical calculations were performed using SPSS for windows, version 13 (SPSS Inc., Chicago, IL, USA).

RESULTS {#sec1-3}
=======

PCR products for SNPs Asp299Gly and Thr399Ile showed fragments of 248 bp \[[Figure 1a](#F1){ref-type="fig"}\] and 396 bp \[[Figure 1b](#F1){ref-type="fig"}\], respectively. After restriction digestion of PCR products by *Nco*1 and *Hin*f1 restriction enzymes for RFLP, the products are shown in Figure [1c](#F1){ref-type="fig"} and [d](#F1){ref-type="fig"} respectively. The presence of digested fragments of 219 and 367 bp\] depicts the presence of SNPs. Single band indicates the presence of homozygous alleles (AA, GG, CC, and TT), and the twin band indicates the heterozygous alleles (AG and CT) with respect to the two SNPs.

![Agarose gel (2%) showing PCR amplification of *TLR-4* (a, b) and restriction digestion of PCR products (c, d). Lanes M:Φ×BsuR1(HaeIII)\[NEB\]; 5-11 (c) and 1,2,6-9 (d): wild-type allele; 1,2 (c) and 3,4,10 (d) heterozygous alleles; 3,4 (c) and 11 (d): homozygous variant allele](IJU-29-37-g002){#F1}

On comparing the frequency of genotypes with respect to Asp299Gly, it was found that AG had significantly high association \[OR = 4.4, 95% CI (1.57--13.26)\] and AA had significantly low association \[OR = 0.39 95% CI (0.18--0.83)\] with CaP \[[Table 2](#T2){ref-type="table"}\]. However, Thr399Ile SNP was not found to be associated with CaP risk \[[Table 2](#T2){ref-type="table"}\].

###### 

*TLR-4* SNP in CaP and benign prostate hyperplasia as when compared with the control

![](IJU-29-37-g003)

The allelic distribution pattern was calculated for various alleles, and in case of Asp299Gly polymorphism frequency of G allele was found to be more in CaP patients when compared with BPH and control, but the differences were not statistically significant \[[Table 3](#T3){ref-type="table"}\]. "A" allele was present at an almost equal level in all the three groups \[[Table 3](#T3){ref-type="table"}\]. Neither of the allele (C and T) frequency with respect to Thr399Ile was found to be significantly associated with either CaP or BPH \[[Table 3](#T3){ref-type="table"}\].

###### 

Allele frequency of the SNP in the *TLR-4* gene in CaP, BPH, and control (frequency in patients with CaP and BPH was compared with respect to the control)
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DISCUSSION {#sec1-4}
==========

The incidence of CaP has been increasing worldwide due to increase in lifespan which is among the major risk factors. Familial clustering and varying prevalence of CaP according to ethnicity are the testimony to genetic basis of its causation.

In this study, an attempt was made to understand the genetic predisposition to CaP, with genetic variability in *TLR-4* gene. *TLR-4* is phylogenetically conserved receptor involved in the recognition of pathogen-associated molecular patterns and endogenous ligands and plays an important role in regulating inflammatory response and signaling the activation of adaptive immunity.\[[@ref17]\] *TLR-4* is expressed in the normal prostate gland. *TLR-4* in prostate cells could act in synergy with innate immune cells and may contribute to an eventual inflammatory process, which in genetically prone individuals could promote carcinogenesis. Therefore, genetic variation of *TLR-4* gene may play a role in determining susceptibility to human diseases which may have an inflammatory component, such as CaP and BPH.

*TLR-4* SNPs exhibit ethnic variation, and there is rarity of Asp299Gly and Thr399Ile polymorphism in Asian ethnic group.\[[@ref18]--[@ref20]\] These SNPs are associated with innate immunity related diseases, such as chronic inflammatory diseases, atherosclerosis, and cancer.\[[@ref10][@ref11]--[@ref13]\]

We examined the genetic diversity of *TLR-4* by SNP analysis at two different positions Asp299Gly and Thr399Ile. It was tested whether genetic difference at this locus was present in CaP patients, BPH patients, and controls in Indian population. We observed that Asp299Gly SNP is associated with CaP risk. Zheng *et al*\[[@ref21]\] in a Swedish population explored the relationship between *TLR-4* sequence variations and risk of CaP. Among eight SNP studied, a sequence variant (11381G/C) in the 3′ untranslated region of *TLR-4* was found to be associated with CaP risk. A few other association studies have reported the relationship between the risk of CaP and the polymorphism in the *TLR-4* gene in European-ancestry populations.\[[@ref6][@ref7]\] In our study, G allele which was a result of nucleotide substitution was found to be present in high frequency in CaP patients when compared with BPH and control population. However, no such association was detected with Thr399Ile SNP. It was confirmed that failure to detect the association of Thr399Ile SNP with CaP was not due to insufficient sample size. Using EpiInfo power calculation software, power of our study is 80%. No significant association of CaP risk with the *TLR-4* polymorphism was found when the comparison was made between two groups: patients with CaP and those with BPH along with the controls. This finding suggests that presence of these SNPs is not very different in the two major prostatic ailments.

It is interesting to note that the said SNPs are present in Indian population in contrast to other ethnic Asian populations. The strength of our study includes use of two independent case--control studies comprising two major ailments associated with prostate that is BPH which is nonmalignant and CaP which is malignant. A trend toward development of BPH was observed in population with Asp299Gly SNP, although the association was not found to be significant. In recent years, inflammation has gained much attention in the etiopathogenesis of cancer.\[[@ref4][@ref5][@ref22]\] This functional polymorphism has been found to be associated with gastric cancer,\[[@ref12][@ref13]\] in which inflammation does play a role as an etiological factor. So, again this SNP might be a predisposing factor for CaP where inflammatory response has been observed.\[[@ref4][@ref5]\] As the presence of this SNP and its association with CaP was observed in our study population, future multidisciplinary research efforts will be needed to fully comprehend the risks and to assess its biologic mechanism that may shed some light on the etiology of this prevalent and age-related disease.
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